3-150927631-TACACACACACACACAC-TACACACACACACACACACAC
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_174878.3(CLRN1):c.*301_*304dupGTGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0039 ( 8 hom., cov: 0)
Exomes 𝑓: 0.00055 ( 0 hom. )
Consequence
CLRN1
NM_174878.3 3_prime_UTR
NM_174878.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.454
Genes affected
CLRN1 (HGNC:12605): (clarin 1) This gene encodes a protein that contains a cytosolic N-terminus, multiple helical transmembrane domains, and an endoplasmic reticulum membrane retention signal, TKGH, in the C-terminus. The encoded protein may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIIa. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 3-150927631-T-TACAC is Benign according to our data. Variant chr3-150927631-T-TACAC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 343808.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00389 (579/148822) while in subpopulation AFR AF= 0.0132 (531/40336). AF 95% confidence interval is 0.0122. There are 8 homozygotes in gnomad4. There are 239 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLRN1 | ENST00000327047 | c.*301_*304dupGTGT | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_174878.3 | ENSP00000322280.1 | |||
ENSG00000260234 | ENST00000569170.5 | n.160+13947_160+13950dupGTGT | intron_variant | Intron 1 of 10 | 1 | ENSP00000457784.1 |
Frequencies
GnomAD3 genomes AF: 0.00388 AC: 577AN: 148710Hom.: 8 Cov.: 0
GnomAD3 genomes
AF:
AC:
577
AN:
148710
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000953 AC: 95AN: 99722Hom.: 0 AF XY: 0.000719 AC XY: 39AN XY: 54260
GnomAD3 exomes
AF:
AC:
95
AN:
99722
Hom.:
AF XY:
AC XY:
39
AN XY:
54260
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000548 AC: 178AN: 324558Hom.: 0 Cov.: 0 AF XY: 0.000397 AC XY: 72AN XY: 181444
GnomAD4 exome
AF:
AC:
178
AN:
324558
Hom.:
Cov.:
0
AF XY:
AC XY:
72
AN XY:
181444
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00389 AC: 579AN: 148822Hom.: 8 Cov.: 0 AF XY: 0.00330 AC XY: 239AN XY: 72456
GnomAD4 genome
AF:
AC:
579
AN:
148822
Hom.:
Cov.:
0
AF XY:
AC XY:
239
AN XY:
72456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Retinitis pigmentosa-deafness syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Retinitis Pigmentosa, Dominant Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
Aug 26, 2019
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at